The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey

Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study

(2017) Veronika K. Jaeger et al.   RHEUMATOLOGY

The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry

(2016) Nienke M. ter Haar et al.   Arthritis & Rheumatology

Recommendations for the management of autoinflammatory diseases

(2015) Nienke M ter Haar et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab

(2015) P Brogan et al.   Pediatric Rheumatology

Effects of the Live Attenuated Measles-Mumps-Rubella Booster Vaccination on Disease Activity in Patients With Juvenile Idiopathic Arthritis

(2013) Marloes W. Heijstek et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

(2012) Nienke ter Haar et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for vaccination in paediatric patients with rheumatic diseases

(2011) M. W. Heijstek et al.   ANNALS OF THE RHEUMATIC DISEASES

Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

(2011) J. B. Kuemmerle-Deschner et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2010) S. van Assen et al.   ANNALS OF THE RHEUMATIC DISEASES

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

(2010) P. Quartier et al.   ANNALS OF THE RHEUMATIC DISEASES

Influenza and Meningococcal Vaccinations Are Effective in Healthy Subjects Treated with the Interleukin-1 -Blocking Antibody Canakinumab: Results of an Open-Label, Parallel Group, Randomized, Single-Center Study

(2010) A. Chioato et al.   Clinical and Vaccine Immunology